Corticosteroids and the risk of glaucoma;Corticosteroïden en het risico van glaucoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 45, 2005, Pages 2485-2489

  Van Boxtel, L A A ^a   Hardus, P L L J ^b   Al Hassan, W S ^b   Van Voorst Vader, P C ^a   Jansonius, N M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Praktijk de Vrije Gang ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; BUDESONIDE; CLOBETASOL; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE;

ARTICLE; BLINDNESS; CONJUNCTIVITIS; CORTICOSTEROID THERAPY; ECZEMA; FAMILY HISTORY; GENERAL PRACTITIONER; GLAUCOMA; HUMAN; LONG TERM EXPOSURE; MEDICAL SPECIALIST; PRESCRIPTION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ADULT; FEMALE; GLAUCOMA; HUMANS; MALE; RISK FACTORS;

EID: 27744436545     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schacker H, Docke WD, Asudallah K. Mechanism involved in the side effects of glucocoticoids. Pharmacol Ther. 2002;96:23-43.
2. McGhee ChNJ, Dean S, Danesh-Meyer H. Locally administered acular corticosteriod, benefits and risks. Drug Saf. 2002;25:33-55.
3. Voorst Vader PC van, Coevorden AM van, Coenraads PJ, Wijdh RHJ, Polak BCP. Atopisch eczeem en cataract. Nederlands Tijdschrift voor Dermatologie en Venereologie. 2004;14:27-9.
4. Clark AF. Steroids, ocular hypertension and glaucoma. J Glaucoma. 1995;4:354-69.
5. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br J Dermatol. 1976;95:207-8.
6. Eisenlohr JE. Glaucoma following the prolonged use of topical steroid medication to the eyelids. J Am Acad Dermatol. 1983;8:878-81.
7. Francois J. Corticosteroid glaucoma. Ann Ophthalmol. 1977;9:1075-80.
8. Miller SJ. Steroid glaucoma. Trans Ophthalmol Soc UK. 1965;85:289-94.
9. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482-91.
10. Nederiandse Vereniging voor Dermatologie en Venereologie. Richtlijnen dermatocortecosteroïden. Alphen aan den Rijn: Van Zuiden Communications; 2001.
11. Weinreb RN, Bloom E, Baxter JD, Alvarado J, Lan N, O'Donnell J, et al. Detection of glucocorticoid receptors in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1981;21:403-7.
12. Shields MB. Textbook of glaucoma. Baltimore: Williams & Wilkins; 1997.
13. Armaly MF. Inheritance of dexamethasone hypertension and glaucoma. Arch Ophthalmol. 1967;77:747-51.
14. Becker B, Hahn KA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol. 1964;57:543-51.
15. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol. 1965;26:187-97.
16. Sahni D, Darley CR, Hawk JL. Glaucoma induced by periorbital topical steroid use - a rare complication. Clin Exp Dermatol. 2004;29:617-9.
17. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-7.
18. Mitchell P, Gumming RG, Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology. 1999;106:2301-6.
19. Opatowsky I, Feldman RM, Gross R, Feldman ST. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology. 1995;102:177-9.
20. Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992:10:505-12.
21. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-13.
22. Katz J, Tielsch JM, Quigley HA, Javitt J, Witt K, Sommer A. Automated suprathreshold screening for glaucoma: the Baltimore Eye Survey. Invest Ophthalmol Vis Sci. 1993;34:3271-7.
23. Bruin-Weller MS de, Bruijnzeel-Koomen CAFM. Topicale immunosuppressiva zoals tacrolimus en pimecrolimus bij de behandeling van constitutioneel eczeem. Ned Tijdschr Geneeskd. 2005;149:1096-100.